Your browser doesn't support javascript.
loading
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.
de Joode, Karlijn; Tol, Jolien; Hamberg, Paul; Cloos, Marissa; Kastelijn, Elisabeth A; Borgers, Jessica S W; Nuij, Veerle J A A; Klaver, Yarne; Herder, Gerarda J M; Mutsaers, Pim G N J; Dumoulin, Daphne W; Oomen-de Hoop, Esther; van Diemen, Nico G J; Libourel, Eduard J; Geraedts, Erica J; Bootsma, Gerben P; van der Leest, Cor H; Peerdeman, Anne L; Herbschleb, Karin H; Visser, Otto J; Bloemendal, Haiko J; van Laarhoven, Hanneke W M; de Vries, Elisabeth G E; Hendriks, Lizza E L; Beerepoot, Laurens V; Westgeest, Hans M; van den Berkmortel, Franchette W P J; Haanen, John B A G; Dingemans, Anne-Marie C; van der Veldt, Astrid A M.
Affiliation
  • de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Cloos M; Department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands.
  • Kastelijn EA; Department of Pulmonology, St. Antonius Hospital Utrecht/Nieuwegein, Utrecht, the Netherlands.
  • Borgers JSW; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Nuij VJAA; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • Klaver Y; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.
  • Herder GJM; Department of Pulmonary Medicine, Meander Medical Center, Amersfoort, the Netherlands.
  • Mutsaers PGNJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Dumoulin DW; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • van Diemen NGJ; Department of Internal Medicine, Bernhoven, Uden, the Netherlands.
  • Libourel EJ; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Geraedts EJ; Department of Pulmonology, Groene Hart Hospital, Gouda, the Netherlands.
  • Bootsma GP; Department of Pulmonology, Zuyderland Medical Center, Heerlen, the Netherlands.
  • van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, the Netherlands.
  • Peerdeman AL; Department of Internal Medicine, Bernhoven, Uden, the Netherlands.
  • Herbschleb KH; Department of Internal Medicine, St. Antonius Hospital Utrecht/Nieuwegein, Utrecht, the Netherlands.
  • Visser OJ; Department of Hematology, Isala Hospital, Zwolle, the Netherlands.
  • Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Hendriks LEL; Department of Pulmonary Diseases GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Beerepoot LV; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.
  • Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.
  • van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
  • Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • van der Veldt AAM; Department of Medical Oncology and Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.
Eur J Cancer ; 160: 261-272, 2022 01.
Article in En | MEDLINE | ID: mdl-34799210
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mortality / Withholding Treatment / SARS-CoV-2 / COVID-19 / Hospitalization / Life Support Care / Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mortality / Withholding Treatment / SARS-CoV-2 / COVID-19 / Hospitalization / Life Support Care / Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2022 Document type: Article Affiliation country: Country of publication: